Scientist Home Future Health Limited splits its revenue into 11 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Total Retail Trading Revenue at $209,623, 99% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Sep 30, 2026
|
Q3 FY2026
Sep 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
|---|---|---|---|---|---|---|---|---|
| Revenue |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Retail Trading Revenue |
—
|
0
+429.3%
share 98.9%
|
—
|
—
|
—
|
0
share 100.0%
|
—
|
—
|
| Scientist Home Cholipolysis Cholic Acid |
—
|
—
|
—
|
0
share 19.5%
|
—
|
—
|
—
|
—
|
| Hydrolyzed Collagen |
—
|
0
share 4.3%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Scientist Home High Concentration Proteinase |
—
|
—
|
0
-12.4%
share 9.2%
|
—
|
0
share 12.2%
|
0
share 31.2%
|
0
share 27.7%
|
—
|
| Scientist Home Mixed Gelatine Hydrolysate |
—
|
—
|
0
-39.9%
share 8.8%
|
0
-39.9%
share 5.4%
|
—
|
—
|
0
share 38.6%
|
0
share 36.8%
|
| Scientist Home Immune Study |
—
|
—
|
0
share 6.7%
|
—
|
—
|
—
|
—
|
—
|
| Scientist Home Fibrosis Study |
—
|
—
|
0
share 6.0%
|
0
share 6.6%
|
—
|
—
|
—
|
—
|
| Scientist Home Vein Cream |
—
|
—
|
—
|
—
|
0
share 4.0%
|
0
share 8.4%
|
0
share 19.0%
|
0
share 21.9%
|
| Prostate Health Research |
—
|
0
share 1.5%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Scientist Home Spermaceti Cream |
—
|
—
|
—
|
—
|
—
|
0
share 4.2%
|
0
share 2.5%
|
0
share 5.5%
|
| Recurrence Research |
—
|
0
share 0.5%
|
—
|
—
|
—
|
—
|
—
|
—
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844)
- Listed as
- SHFH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Kwun Tong, Hong Kong
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 2032609
Other Perfumes, Cosmetics & Other Toilet Preparations companies
- Colgate Palmolive Co CL
- Haleon plc HLN
- Estee Lauder Companies Inc EL
- e.l.f. Beauty, Inc. ELF
- Interparfums Inc IPAR
- Coty Inc. COTY
- EDGEWELL PERSONAL CARE Co EPC
- Oddity Tech Ltd ODD
All 22 Perfumes, Cosmetics & Other Toilet Preparations companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.